(ASCO in Action) Apr 12, 2018 - An analysis published today in the American Society of Clinical Oncology’s (ASCO) Journal of Oncology Practice (JOP), suggests that including cancer drug costs in bundled payments under Medicare risks destabilizing the cancer care delivery environment.
Read Article
Dean Gesme, MD (Posted: April 13, 2018)
There is no quicker way to "burn out" physicians than to put them "at risk" for expenses that they cannot reasonably and fairly control -- such as drug prices!
Professor and Director, Division of Hematology Oncology...
